Medication and Device Labeling

Labelling of injectable medicines and fluids and the devices used to deliver these (including non-labelling) has been identified as a patient safety issue. Safe use of medicines is a key component of Quality Use of Medicines (QUM), which forms part of Australia’s National Medicines Policy.

In 2015 the Australian Commission on Safety and Quality in Health Care (ACSQHC) released their latest update to the publication National Recommendations for User-applied Labelling of Injectable Medicines, Fluids and Lines. Click here for more information about these recommendations including a link to download the full copy.

The ACSQHC clearly states on their website:

“Using the Labelling Standard is mandatory for meeting the National Safety and Quality Health Service (NSQHS) Standards – in particular, NSQHS Standard 4: Medication Safety.”

The publication aims to:

  • Promote safe use of injectable medicines
  • Provide standardisation for user-applied labelling of injectable medicines
  • Provide minimum requirements for user-applied labelling of injectable medicines

IntelliLearn’s Medication and Device Labelling course is mapped directly to the Commission’s publication.

Medication and Device Labelling and Med+Safe form IntelliLearn’s Medication Safety library and offer organisations the opportunity to address education and compliance in these high risk areas.